These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28606098)

  • 1. Determining the longitudinal validity and meaningful differences in HRQL of the PedsQL™ Sickle Cell Disease Module.
    Panepinto JA; Paul Scott J; Badaki-Makun O; Darbari DS; Chumpitazi CE; Airewele GE; Ellison AM; Smith-Whitley K; Mahajan P; Sarnaik SA; Charles Casper T; Cook LJ; Leonard J; Hulbert ML; Powell EC; Liem RI; Hickey R; Krishnamurti L; Hillery CA; Brousseau DC;
    Health Qual Life Outcomes; 2017 Jun; 15(1):124. PubMed ID: 28606098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaso-occlusive painful events in sickle cell disease: impact on child well-being.
    Brandow AM; Brousseau DC; Pajewski NM; Panepinto JA
    Pediatr Blood Cancer; 2010 Jan; 54(1):92-7. PubMed ID: 19653296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can PROMIS domains of pain and physical functioning detect changes in health over time for children with sickle cell disease?
    Singh A; Dasgupta M; Simpson PM; Brousseau DC; Panepinto JA
    Pediatr Blood Cancer; 2020 May; 67(5):e28203. PubMed ID: 32026613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PedsQL™ sickle cell disease module: feasibility, reliability, and validity.
    Panepinto JA; Torres S; Bendo CB; McCavit TL; Dinu B; Sherman-Bien S; Bemrich-Stolz C; Varni JW
    Pediatr Blood Cancer; 2013 Aug; 60(8):1338-44. PubMed ID: 23441057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A psychometric evaluation of the PedsQL Family Impact Module in parents of children with sickle cell disease.
    Panepinto JA; Hoffmann RG; Pajewski NM
    Health Qual Life Outcomes; 2009 Apr; 7():32. PubMed ID: 19371442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PedsQL™ Multidimensional Fatigue Scale in sickle cell disease: feasibility, reliability, and validity.
    Panepinto JA; Torres S; Bendo CB; McCavit TL; Dinu B; Sherman-Bien S; Bemrich-Stolz C; Varni JW
    Pediatr Blood Cancer; 2014 Jan; 61(1):171-7. PubMed ID: 24038960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of health related quality of life in children with immune thrombocytopenia with the PedsQL™ 4.0 Generic Core Scales: a study on behalf of the pays de Loire pediatric hematology network.
    Strullu M; Rakotonjanahary J; Tarral E; Savagner C; Thomas C; Méchinaud F; Reguerre Y; Poignant S; Boutet A; Bassil J; Médinger D; Quemener E; Young NL; Rachieru P; Klaassen RJ; Pellier I
    Health Qual Life Outcomes; 2013 Nov; 11():193. PubMed ID: 24225051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construct validity and impact of mode of administration of the PedsQL™ among a pediatric injury population.
    Kruse S; Schneeberg A; Brussoni M
    Health Qual Life Outcomes; 2014 Nov; 12():168. PubMed ID: 25433795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of the child health questionnaire for use in children with sickle cell disease.
    Panepinto JA; O'Mahar KM; DeBaun MR; Rennie KM; Scott JP
    J Pediatr Hematol Oncol; 2004 Sep; 26(9):574-8. PubMed ID: 15342984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the PedsQL™ Sickle Cell Disease Module items: qualitative methods.
    Panepinto JA; Torres S; Varni JW
    Qual Life Res; 2012 Mar; 21(2):341-57. PubMed ID: 21638090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in children with sickle cell disease: child and parent perception.
    Panepinto JA; O'Mahar KM; DeBaun MR; Loberiza FR; Scott JP
    Br J Haematol; 2005 Aug; 130(3):437-44. PubMed ID: 16042695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically meaningful interpretation of pediatric health-related quality of life in sickle cell disease.
    Beverung LM; Varni JW; Panepinto JA
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):128-33. PubMed ID: 24942019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of family income and sickle cell disease on the health-related quality of life of children.
    Panepinto JA; Pajewski NM; Foerster LM; Sabnis S; Hoffmann RG
    Qual Life Res; 2009 Feb; 18(1):5-13. PubMed ID: 18989755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Abilities Moderate the Effect of Disease Severity on Health-Related Quality of Life in Pediatric Sickle Cell Disease.
    Hardy SJ; Bills SE; Wise SM; Hardy KK
    J Pediatr Psychol; 2018 Sep; 43(8):882-894. PubMed ID: 29659914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children.
    Brousseau DC; Scott JP; Badaki-Makun O; Darbari DS; Chumpitazi CE; Airewele GE; Ellison AM; Smith-Whitley K; Mahajan P; Sarnaik SA; Casper TC; Cook LJ; Dean JM; Leonard J; Hulbert ML; Powell EC; Liem RI; Hickey R; Krishnamurti L; Hillery CA; Nimmer M; Panepinto JA;
    Blood; 2015 Oct; 126(14):1651-7. PubMed ID: 26232172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
    Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
    Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease.
    Sarri G; Bhor M; Abogunrin S; Farmer C; Nandal S; Halloway R; Revicki DA
    Health Qual Life Outcomes; 2018 May; 16(1):99. PubMed ID: 29784054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report.
    Román ME; Highland J; Retherford D; Pan AY; Panepinto JA; Brandow AM
    Pediatr Blood Cancer; 2020 Dec; 67(12):e28698. PubMed ID: 33034107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content validity of the PedsQL™ 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8-45.
    Varni JW; Curtis BH; Abetz LN; Lasch KE; Piault EC; Zeytoonjian AA
    Qual Life Res; 2013 Oct; 22(8):2169-81. PubMed ID: 23269541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal validity and responsiveness of the Food Allergy Quality of Life Questionnaire - Parent Form in children 0-12 years following positive and negative food challenges.
    DunnGalvin A; Cullinane C; Daly DA; Flokstra-de Blok BM; Dubois AE; Hourihane JO
    Clin Exp Allergy; 2010 Mar; 40(3):476-85. PubMed ID: 20210816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.